Overall Status

Active, not recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

AstraZeneca (1)

H3 Biomedicine Inc. (1)

Collaborator

Eisai Inc. (1)

Intervention

azd5363 (1)

h3b-6545 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

er positive

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting

Advanced Solid Malignancy
+13 more

AZD5363

Los Angeles, California
+33 more

Dec 22, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting

Breast Neoplasms
+7 more

H3B-6545

Goodyear, Arizona
+38 more

Jun 29, 2022